Results 111 to 120 of about 2,055 (188)

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer. [PDF]

open access: yesJ Immunother Cancer
Li C   +27 more
europepmc   +1 more source

FASN Inhibition Enhances the Efficacy of Chemotherapy in Colorectal Cancer by Inhibiting the DNA Damage Response. [PDF]

open access: yesCancer Res
Banerjee M   +14 more
europepmc   +1 more source

PARP Inhibition Shifts Murine Myeloid Cells Toward a More Tolerogenic Profile In Vivo. [PDF]

open access: yesBiomolecules
Pittaluga-Villarreal JR   +5 more
europepmc   +1 more source

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching. [PDF]

open access: yesProtein Cell
Liu C   +15 more
europepmc   +1 more source

Shared and non-overlapping functions of RECQL4 and BLM helicases in chemotherapeutics-induced glioma cell responses. [PDF]

open access: yesBMC Cancer
Wojnicki K   +6 more
europepmc   +1 more source

College of the Pacific Commencement Ceremony [PDF]

open access: yes, 1990
University of the Pacific
core  

Home - About - Disclaimer - Privacy